Related references
Note: Only part of the references are listed.Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer
Shirish Gadgeel et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
How to make the best use of immunotherapy as first-line treatment of advanced/metastatic non-small-cell lung cancer
S. Peters et al.
ANNALS OF ONCOLOGY (2019)
The Japanese Lung Cancer Society Guideline for non-small cell lung cancer, stage IV
Hiroaki Akamatsu et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2019)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Primary results from Japanese phase I study of pembrolizumab plus chemotherapy as front-line therapy for advanced NSCLC
Takayasu Kurata et al.
ANNALS OF ONCOLOGY (2019)
Pan-Asian adapted Clinical Practice Guidelines for the management of patients with metastatic non-small-cell lung cancer: a CSCO-ESMO initiative endorsed by JSMO, KSMO, MOS, SSO and TOS
Y. -L. Wu et al.
ANNALS OF ONCOLOGY (2019)
Advanced non-small cell lung cancer - Treatment with Pembrolizumab
Antonio Silvinato et al.
REVISTA DA ASSOCIACAO MEDICA BRASILEIRA (2019)
Pembrolizumab as first-line therapy for metastatic non-small-cell lung cancer
Martin Reck
IMMUNOTHERAPY (2018)
Pembrolizumab plus Chemotherapy in Metastatic Non-Small-Cell Lung Cancer
L. Gandhi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunotherapy in the Asiatic population: any differences from Caucasian population?
Lunxi Peng et al.
JOURNAL OF THORACIC DISEASE (2018)
CLINICAL ONCOLOGY Windows open for cancer immunotherapy
Lizza E. Hendriks et al.
NATURE (2018)
Pembrolizumab plus Chemotherapy for Squamous Non-Small-Cell Lung Cancer
L. Paz-Ares et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
S. Novello et al.
ANNALS OF ONCOLOGY (2016)
Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study
Corey J. Langer et al.
LANCET ONCOLOGY (2016)
Non-small cell lung cancer: current treatment and future advances
Cecilia Zappa et al.
TRANSLATIONAL LUNG CANCER RESEARCH (2016)
Differences in outcome and toxicity between Asian and caucasian patients with lung cancer treated with systemic therapy
Ross A. Soo et al.
FUTURE ONCOLOGY (2012)
Ethnic Differences in Survival Outcome in Patients with Advanced Stage Non-small Cell Lung Cancer Results of a Meta-Analysis of Randomized Controlled Trials
Ross A. Soo et al.
JOURNAL OF THORACIC ONCOLOGY (2011)
Share Paper
